Literature DB >> 25910197

Five years of molecular radiotherapy growth in the UK: survey results from 2007 to 2012.

Bruno Rojas1, Claire Hooker, Daniel R McGowan, Matthew J Guy.   

Abstract

Mesh：

Year:  2015        PMID： 25910197     DOI： 10.1097/MNM.0000000000000306

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN： 0143-3636            Impact factor:   1.690


× No keyword cloud information.
  6 in total

Review 1.  Time to demand dosimetry for molecular radiotherapy?

Authors:  D R McGowan; M J Guy
Journal:  Br J Radiol       Date:  2015-01-09       Impact factor: 3.039

2.  InfuShield: a shielded enclosure for administering therapeutic radioisotope treatments using standard syringe pumps.

Authors:  Dominic P Rushforth; Brenda E Pratt; Sarah J Chittenden; Iain S Murray; Louise Causer; Matthew J Grey; Jonathan I Gear; Yong Du; Glenn D Flux
Journal:  Nucl Med Commun       Date:  2017-03       Impact factor: 1.690

Review 3.  Imaging and dosimetry for radium-223: the potential for personalized treatment.

Authors:  Glenn D Flux
Journal:  Br J Radiol       Date:  2017-06-27       Impact factor: 3.039

Review 4.  Subcellular Targeting of Theranostic Radionuclides.

Authors:  Bas M Bavelaar; Boon Q Lee; Martin R Gill; Nadia Falzone; Katherine A Vallis
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.988

5.  The internal dosimetry user group position statement on molecular radiotherapy.

Authors:  Jonathan Gear; Daniel McGowan; Bruno Rojas; Allison J Craig; April-Louise Smith; Catherine J Scott; James Scuffam; Matthew Aldridge; Jill Tipping
Journal:  Br J Radiol       Date:  2021-08-25       Impact factor: 3.629

6.  Eighty per cent more patients in 10 years of UK molecular radiotherapy: Internal Dosimetry Users Group survey results from 2007 to 2017.

Authors:  Bruno Rojas; Daniel R McGowan; Matthew J Guy; Jill Tipping; Matthew Aldridge; Jonathan Gear
Journal:  Nucl Med Commun       Date:  2019-07       Impact factor: 1.690
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.